A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease
Marie Binvignat, Federica Martina, Fabien Pitoiset, Alexandra Roux, Roberta Lorenzon, Pierre Hodara, Pierre Barennes, Hélène Vantomme, Michèle Sastre, Signe Hässler, Claire Ribet, Alice Courties, Vanessa Mhanna, Paul Stys, Leslie Adda, , Encarnita Mariotti‐Ferrandiz
The paper identifies a shared Treg dysfunction signature across rheumatic diseases, suggesting a therapeutic window of opportunity for Treg-targeted treatments.
bioRxiv · Sep 27, 2026 · PreprintImmunology